0001179110-14-003194.txt : 20140220 0001179110-14-003194.hdr.sgml : 20140220 20140220155037 ACCESSION NUMBER: 0001179110-14-003194 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140218 FILED AS OF DATE: 20140220 DATE AS OF CHANGE: 20140220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 WEST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 675 WEST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WHEELER CRAIG A CENTRAL INDEX KEY: 0001229450 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 14629473 4 1 edgar.xml FORM 4 - X0306 4 2014-02-18 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001229450 WHEELER CRAIG A C/O MOMENTA PHARMACEUTICALS, INC. 675 WEST KENDALL STREET CAMBRIDGE MA 02142 1 1 0 0 President Common Stock 2014-02-18 4 S 0 1687 17.96 D 320508 D Common Stock 2014-02-18 4 A 0 70000 0 A 390508 D Common Stock 2014-02-19 4 S 0 2110 17.86 D 388398 D Common Stock 252106 I Craig Wheeler revocable trust Stock Option (Righ to Buy) 17.96 2014-02-18 4 A 0 140000 0 A 2014-05-18 2024-02-18 Common Stock 140000 1192000 D This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on November 25, 2009. Represents 70,000 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, and subject to a restricted stock agreement to be entered between the Company and Mr. Wheeler. Pursuant to the restricted stock agreement, 25% of the shares of restricted Common Stock shall vest on February 18, 2015 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter. Represents an option granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria, the shares subject to such option vest as to 6.25% of the shares at the end of each three-month period following the grant date. /s/ Eric Shaff as attorney in fact 2014-02-20